The European Medicines Agency is to run another staff survey so that it can begin to plan its relocation to Amsterdam and determine how many of its employees are likely to go along with it, according to executive director Guido Rasi. He also said that while having to move into temporary premises in Amsterdam at the beginning of 2019 was “not ideal,” the agency should still be able to carry on its core activities without “major disruption.”
Two key challenges for the agency, which is having to move out of London because of the UK’s decision to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?